21 June 2024

CICON 2024

26 June 2023

First patient dosed in phase 2 MATISSE trial of IPH5201

10 April 2023

AACR annual meeting 2023

24 February 2023

IPH5201 (CD39 mAb): initiation of Phase 2 clinical trial MATISSE

IPH5201 (CD39 mAb): initiation of Phase 2 clinical trial MATISSE
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more